Singapore Markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,443.10 +61.75 (+0.74%) BTC-USD
62,879.50 +1,487.92 (+2.42%) CMC Crypto 200
1,303.25 -54.76 (-4.03%)
BeiGene, Ltd. (BGNE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 164.44 |
| Open | 166.06 |
| Bid | 168.45 x 200 |
| Ask | 168.85 x 100 |
| Day's range | 165.65 - 169.38 |
| 52-week range | 126.97 - 245.74 |
| Volume | |
| Avg. volume | 214,879 |
| Market cap | 19.129B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.54 |
| Earnings date | 31 Jul 2024 - 07 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 270.69 |
Simply Wall St.BeiGene First Quarter 2024 Earnings: Beats Expectations
BeiGene ( NASDAQ:BGNE ) First Quarter 2024 Results Key Financial Results Revenue: US$751.7m (up 68% from 1Q 2023). Net...
GuruFocus.comDecoding BeiGene Ltd (BGNE): A Strategic SWOT Insight
Insightful Analysis of BeiGene Ltd's Financials and Strategic Positioning
Business WireBeiGene Reports First Quarter 2024 Financial Results and Business Updates
SAN MATEO, Calif., May 08, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced results from the first quarter 2024 and business highlights.
© 2024 Yahoo. All rights reserved.